Biomarkers and Translational Tools (BTT) Community

Community Goals

Scientific Expertise:
  • The Biomarkers and Translational Tools (BTT) Community facilitates interactions among experts across multidisciplinary fields to foster translational science with a focus on individuals via patient care and society via healthcare. The interactions are through social media, email blasts, and teleconferences with focused scientific content.
Catalyst for Innovation:
  • The BTT Community is a catalyst for innovation by sponsoring a range of scientific programs at the Annual Meeting focused on biomarker and translational tools.
Influence and Impact:
  • The BTT Community is the lead group engaged in promoting the use of biomarkers and other translational tools for optimizing drug development and patient care.
Education and Communication:
  • The BTT Community offers educational opportunities via the Annual Meeting and other fora
Organizational Effectiveness:
  • Leadership within BTT will be expanded by establishing a Network Steering Committee.
  • The BTT Community has regularly scheduled teleconferences and utilizes social media to engage members throughout the year.
  • The BTT Community fosters the career of its members by assisting in recognizing members for individual achievements and contributions to ASCPT, sponsoring educational programs, and providing opportunities for networking activities throughout an individual’s career.

Join the LinkedIn Group.

Upcoming Webinar
ASCPT Members-Only Webinar Presented by the Biomarkers & Translational Tools (BTT) Community
Title: Biomarkers and Experimental Human Models as a Supportive Evidence of Efficacy and Safety in Clinical Development and Their Usage in Clinical Practice
Date and Time: Tuesday, July 17, 2018, 12:00 PM ET
Speaker: Maria Burian, MD, MBA
Moderator: Jitendra Kanodia, PhD
Description: Biomarkers and experimental human models provide supportive evidence of clinical efficacy and safety in drug development process. Use of biomarkers in clinical development helps to shorten time to complete development programs or time to reach a critical decision point as well as to reduce samples size in clinical trials. Biomarkers can be utilized in clinical practice to guide therapy or can be developed as a drug product. This presentation will: a) review biomarker definition and classifications used in clinical development and clinical practice; b) present cases with biomarker and experimental human model applications in clinical development used with the purpose to explain interindividual variability or to clarify mechanism of drug action) c) present cases with biomarkers used as a stratification tool in clinical practice (NT-proBNP-guided therapy in heart failure) or developed as a drug product (BNP as a recombinant drug product to treat heart failure).
Registration: https://attendee.gotowebinar.com/register/8169833581081545985

Past Webinars

Ana Caroline Costa Sa, PhD

Community Chair


Jitendra Kanodia, PhD

Community Vice Chair


Richard A. Graham, PhD

Community Past Chair


Photo Gallery
Recent News
Contact Us